Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Joint Stock Company Kaspi.kz | KSPI | Sep 27, 2024 | 102.99 | -1.08 |
Jones Lang LaSalle | JLL | Sep 27, 2024 | 266.10 | -2.17 |
Journey Medical | DERM | Sep 27, 2024 | 5.72 | +4.57 |
Jowell Global | JWEL | Sep 27, 2024 | 1.35 | -2.17 |
JOYY ADR | YY | Sep 27, 2024 | 37.70 | +0.16 |
JP Morgan Chase | JPM | Sep 27, 2024 | 210.50 | +0.34 |
JP Morgan Chase & Co EE Pref | JPM-C | Sep 27, 2024 | 25.74 | 0.00 |
JP Morgan Chase & Co GG Pref | JPM-J | Sep 27, 2024 | 23.95 | +0.17 |
JP Morgan Chase & Co Ser DD Pref | JPM-D | Sep 27, 2024 | 25.59 | +0.04 |
JPMorgan Nasdaq Equity Premium Income ETF | JEPQ | Sep 27, 2024 | 54.80 | -0.16 |
Jumia Technologies ADR | JMIA | Sep 27, 2024 | 5.30 | +1.73 |
Junee Limited - Ordinary Shares | JUNE | Sep 27, 2024 | 4.59 | -1.92 |
Junior Gold Miners ETF Market Vectors | GDXJ | Sep 27, 2024 | 49.62 | -3.07 |
Juniper Networks | JNPR | Sep 27, 2024 | 38.95 | +0.33 |
JVSPAC Acquisition | JVSAU | Sep 27, 2024 | 10.64 | 0.00 |
JVSPAC Acquisition | JVSA | Sep 27, 2024 | 10.34 | +0.10 |
JX Luxventure | JXJT | Sep 27, 2024 | 1.85 | -2.12 |
Kadant | KAI | Sep 27, 2024 | 335.08 | +0.23 |
Kairos Pharma | KAPA | Sep 27, 2024 | 1.54 | 0.00 |
Kairous Acquisition | KACL | Sep 27, 2024 | 12.20 | 0.00 |
Kaiser Aluminium | KALU | Sep 27, 2024 | 73.18 | +0.08 |
Kaival Brands Innovations Group | KAVL | Sep 27, 2024 | 1.15 | +5.50 |
Kaixin Auto | KXIN | Sep 27, 2024 | 0.09 | -15.89 |
Kala Bio | KALA | Sep 27, 2024 | 5.35 | +1.90 |
Kaltura | KLTR | Sep 27, 2024 | 1.35 | +4.65 |
KalVista Pharmaceuticals | KALV | Sep 27, 2024 | 12.34 | +23.40 |
Kamada | KMDA | Sep 27, 2024 | 5.41 | +0.74 |
Kandi Technologies Group | KNDI | Sep 27, 2024 | 1.72 | +8.86 |
Kanzhun ADR | BZ | Sep 27, 2024 | 17.18 | +6.58 |
Karat Packaging | KRT | Sep 27, 2024 | 25.83 | -0.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.